XML 11 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 155,149 $ 188,657
Investment securities, available-for-sale 410,181 250,208
Accounts receivable, net 98,209 98,267
Interest and other receivables 12,154 4,083
Inventory 61,041 35,819
Prepaid expenses 51,550 39,091
Total current assets 788,284 616,125
Property and equipment, net 3,988 4,612
Operating lease right-of-use assets 44,253 51,855
Intangible assets, net 105,515 65,490
Restricted cash 8,770 5,770
Long-term inventory 25,699 4,628
Other assets 359 476
Total assets 976,868 748,956
Liabilities and stockholders’ equity    
Accounts payable 19,081 17,543
Accrued liabilities 324,864 236,711
Total current liabilities 343,945 254,254
Operating lease liabilities 40,421 47,800
Other long-term liabilities 15,322 15,147
Total liabilities 399,688 317,201
Commitments and contingencies (Note 9)
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 5,000,000 shares authorized at September 30, 2024 and December 31, 2023; no shares issued and outstanding at September 30, 2024 and December 31, 2023 0 0
Common stock, $0.0001 par value; 225,000,000 shares authorized at September 30, 2024 and December 31, 2023; 166,351,715 shares and 164,650,219 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively 16 16
Additional paid-in capital 2,924,434 2,862,552
Accumulated deficit (2,348,128) (2,430,837)
Accumulated other comprehensive income 858 24
Total stockholders’ equity 577,180 431,755
Total liabilities and stockholders’ equity $ 976,868 $ 748,956